Medical Management of Peyronie's Disease
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Peyronie's disease (PD) is a wound‐healing disorder in which a fibrotic plaque forms in the tunica albuginea layer of the penis. It clinically presents as any combination of penile pain, angulation, and erectile dysfunction. Recent studies indicate that PD has a prevalence of 3%–9% in adult men. Although the exact etiology has not been established, PD likely results from a predisposing genetic susceptibility combined with an inciting event such as microtrauma during intercourse. During the initial acute phase (6–18 months), the condition may progress, stabilize, or regress. For this reason authorities recommend a more conservative treatment approach, with a trial of oral and/or intralesional pharmacotherapy, before surgical reconstruction is considered. Oral therapies most commonly employed include tocopherol (vitamin E) and paraaminobenzoate (Potaba), with colchicine, tamoxifen, propoleum, and acetyl‐l‐carnitine being used less often. There are a limited number of long‐term placebo‐controlled studies with these oral agents, and for the most part, studies have failed to show a consistent beneficial effect. Intralesional injection therapy for PD is more commonly used as a first‐line therapy. The current standard of care includes injection with interferon‐α‐2b, verapamil, or collagenase. Interferon‐α‐2b, in particular, has been documented in a large, multicenter, placebo‐controlled study to show significant benefit over placebo in decreasing penile curvature, plaque size, penile pain, and plaque density. However, intralesional interferon is associated with posttreatment flu‐like symptoms unless patients are premedicated with a nonsteroid anti‐inflammatory agent. Other available therapies that have not consistently shown efficacy in placebo‐controlled studies include corticosteroids, orgotein, radiation, and extracorporeal shockwave therapy. Surgery is considered when men with PD do not respond to conservative or medical therapy for approximately 1 year and cannot perform satisfactory sexual intercourse. Ongoing basic research in PD will likely identify future targets for medical exploitation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381
Risk factors for Peyronie's disease: a case‐control study
BJEKIC, M. D., VLAJINAC, H. D., SIPETIC, S. B., & MARINKOVIC, J. M. (2006) · BJU International · doi:10.1111/j.1464-410x.2006.05969.x · Cited by 154
Duncan, M. R., Berman, B., & Nseyo, U. O. (1991) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599109024539 · Cited by 132
Role of oxidative stress and antioxidants in Peyronie’s disease
Sikka, S. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900880 · Cited by 77
Self-citationRadiation Increases Fibrogenic Cytokine Expression by Peyronie’s Disease Fibroblasts
MULHALL, J. P., BRANCH, J., LUBRANO, T., & SHANKEY, T. V. (2003) · Journal of Urology · doi:10.1097/01.ju.0000070860.78370.08 · Cited by 22
Cited by
EAU guidelines on penile curvature
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., Vardi, Y., & Wespes, E. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.040 · Cited by 309
“Conservative treatment of Peyronie’s disease is primarily focused on patients in the early stage when symptoms are present and the plaque is not densely fibrotic or calcified [15].”
BackgroundUnderstanding the course of Peyronie's disease
Garaffa, G., Trost, L. W., Serefoglu, E. C., Ralph, D., & Hellstrom, W. J. G. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12129 · Cited by 75
Self-citationTwidwell, J., & Levine, L. (2016) · International Journal of Impotence Research · doi:10.1038/ijir.2015.22 · Cited by 51
Metadata
- Authors
- Hellstrom, W. J. G.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2009-07-08
- Volume
- 30
- Issue
- 4
- Pages
- 397-405
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W2012268804
- Cited by
- 68
- References
- 6
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical Management of Peyronie's Disease. https://app.cochat.ai/papers/10.2164/jandrol.108.006221
- The paper
- Hellstrom, W. J. G. (2009). Medical Management of Peyronie's Disease. Journal of Andrology. https://doi.org/10.2164/jandrol.108.006221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.